I think progress is good. They have recruited within 3 months of schedule and more importantly, recruited exactly who they wanted (according to stamler at AAN) (? Possibly due to natural history study insights)
I got the gist of Ashley Palls poster but have a average background in chemistry so some of it is over my head. As expected though, she presented a case that supports ATH434 for FA (otherwise why would alterity go public with research like this?)
why bring in FA now is my query though. Is it a backup in case MSA doesn't work out (this is my baggage from another biotech that rug pulled its primary indication straight after announcing a 2nd). That looks unlikely here at this point in the game. Maybe the FA research is too compelling to not publish...
i think the small cap US biotech market had jitters last night after Annovis disappointed with is phase II/III. (Patient selection anyone??)
anyway, high risk, high reward. Imo
- Forums
- ASX - By Stock
- ATH
- Ann: Alterity Presents New Data on ATH434
Ann: Alterity Presents New Data on ATH434, page-8
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $10.54K | 2.185M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 83226460 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 20397608 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 83226460 | 0.004 |
50 | 53735564 | 0.003 |
16 | 38993014 | 0.002 |
12 | 93270101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 20297608 | 17 |
0.006 | 14380922 | 20 |
0.007 | 14674670 | 16 |
0.008 | 14085875 | 15 |
0.009 | 6171000 | 7 |
Last trade - 10.13am 07/06/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |